Patents by Inventor Poorna Yalagala

Poorna Yalagala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230364157
    Abstract: The present invention provides compositions comprising phosphatidylcholine derived compounds carrying an omega-3 fatty acid for use in prophylaxis or therapy, particularly when administered systemically. This invention further relates to a modified krill oil composition enriched in LPC-DHA and LPC-EPA, methods of making and methods of using to treat neurological and ocular disorders.
    Type: Application
    Filed: July 26, 2023
    Publication date: November 16, 2023
    Inventors: Finn Myhren, Petter-Arnt Hals, Nils Hoem, Andreas Berg Storsve, Papasani V. Subbaiah, Poorna Yalagala, Sugasini Dhavamani, Leon Tai
  • Patent number: 11744864
    Abstract: The present invention provides compositions comprising phosphatidylcholine derived compounds carrying an omega-3 fatty acid for use in prophylaxis or therapy, particularly when administered systemically. This invention further relates to a modified krill oil composition enriched in LPC-DHA and LPC-EPA, methods of making and methods of using to treat neurological and ocular disorders.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: September 5, 2023
    Assignee: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Finn Myhren, Petter-Arnt Hals, Nils Hoem, Andreas Berg Storsve, Papasani V. Subbaiah, Poorna Yalagala, Sugasini Dhavamani, Leon Tai
  • Publication number: 20210308193
    Abstract: The present invention provides compositions comprising phosphatidylcholine derived compounds carrying an omega-3 fatty acid for use in prophylaxis or therapy, particularly when administered systemically. This invention further relates to a modified krill oil composition enriched in LPC-DHA and LPC-EPA, methods of making and methods of using to treat neurological and ocular disorders.
    Type: Application
    Filed: March 31, 2021
    Publication date: October 7, 2021
    Inventors: Finn Myhren, Petter-Arnt Hals, Nils Hoem, Andreas Berg Storsve, Papasani V. Subbaiah, Poorna Yalagala, Sugasini Dhavamani, Leon Tai
  • Patent number: 10555957
    Abstract: Described herein are at least compounds and formulations that can be or contain a docosahexaenoic acid-lysophosphatidylcholine (DHA-LPC) and/or eicosapenteanoic acid-lysophosphatidylcholine (EPA-LPC). Also described herein are at least methods of making and using the compositions and formulations DHA-LPC and/or EPA-LPC.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: February 11, 2020
    Assignee: The Board of Trustees of The University of Illinois
    Inventors: Papasani V. Subbaiah, Poorna Yalagala, Sugasini Dhavamani
  • Publication number: 20180325924
    Abstract: Described herein are at least compounds and formulations that can be or contain a docosahexaenoic acid-lysophosphatidylcholine (DHA-LPC) and/or eicosapenteanoic acid-lysophosphatidylcholine (EPA-LPC). Also described herein are at least methods of making and using the compositions and formulations DHA-LPC and/or EPA-LPC.
    Type: Application
    Filed: May 10, 2018
    Publication date: November 15, 2018
    Inventors: PAPASANI V. SUBBAIAH, Poorna Yalagala, Sugasini Dhavamani